Description
Latin name
Strepsils intensive
Release form
lozenges
packaging 24 pcs
Indications
As a symptomatic agent to relieve sore throat in infectious and inflammatory diseases of the oral cavity and pharynx.
Special instructions
Diabetes patients should take into account that the tablet contains about 2.5 g of caxapa. In the case of a combination of sore throat with a significant increase in body temperature, taking the drug can only be recommended by a doctor.
If determination of 17-ketosteroids is necessary, the drug should be discontinued 48 hours before the study. While maintaining a high temperature, the appearance of a headache, or other undesirable phenomena, you should consult a doctor. Do not exceed the dose indicated in the instructions.
Composition
1 tablet for resorption contains:
Active ingredients: flurbiprofen 8, 75 mg
Excipients: macrogol 300 5.47 mg, potassium hydroxide 2.19 mg, lemon flavor [502904 A) 3.6 mg, levomenthol 2 mg, honey 50.4 mg, liquid sucrose 1407 mg, dextrose 1069 mg
Dosing and Administration
Tablets must be absorbed in the oral cavity until completely dissolved. When resorption, the tablet should be moved throughout the oral cavity, in order to avoid damage to the mucous membrane at the site of resorption. It is recommended that adults and children over 12 years of age take one tablet as needed. Do not take more than five tablets within 24 hours. Do not take pills for more than 3 days.
Side effects
Side reactions are mainly associated with a distortion of taste and elements of paresthesia (burning, pricking or tingling). Possible ulceration of the oral mucosa.
From the digestive tract: dyspeptic symptoms (nausea, vomiting, heartburn, diarrhea), NSAID gastropathy, abdominal pain, impaired liver function with prolonged use in large doses – ulceration of the gastrointestinal mucosa, bleeding (gastrointestinal, gingival, hemorrhoidal).
From the cardiovascular system: increased blood pressure, tachycardia, heart failure.
From the hemopoietic organs: rarely – anemia (iron deficiency, hemolytic, aplastic), agranulocytosis, leukopenia, thrombocytopenia.
From the nervous system: headache, dizziness, drowsiness / insomnia, asthenia, depression, amnesia, tremor, agitation, rarely – ataxia, paresthesia, impaired consciousness.
From the urinary system: tubulointerstitial nephritis, impaired renal function, edematous syndrome.
Allergic reactions: skin rash, itching, urticaria, bronchospasm, photosensitivity, Quincke’s edema, anaphylactic shock.
Other: hearing loss, tinnitus, increased sweating.
Drug Interactions
Inductors of microsomal oxidation in the liver (phenytoin, ethanol, barbiturates, rifampicin, phenylbugazone, tricyclic antidepressants) increase the production of hydroxylated active metabolites.
Reduces the effectiveness of uricosuric drugs, enhances the action of anticoagulants (increases the risk of bleeding), antiplatelet agents, fibrinolytics, side effects of mineral and glucocorticosteroids, estrogen reduces the effectiveness of hypotensive and diuretics enhances the hypoglycemic effect of sulfonylurea derivatives. Increases the concentration in the blood of lithium preparations, methotrexate.
Overdose
Symptoms of an overdose of flurbiprofen may occur in the form of: when taken 2 g – drowsiness, more than 1.5 g – agitation, 2.5-4 g – nausea, headache, dizziness, epigastric pain, diplopia, myositis, hypotension consciousness up to a coma. In case of overdose, the drug should be discontinued, treatment: symptomatic.
Storage conditions
Store in a dry place at a temperature not exceeding 25 C. Keep out of the reach and sight of children.
Shelf life
3 years.
D ystvuyushtee substance
Flurbiprofen
Terms and conditions vacation holiday srdl vacation without holiday pvc vacation prescription
Dosage form
tablets
Reckitt Benckiser, UK
